Short Description of This Case
Aetna has agreed to pay $6.2M to settle claims that the company improperly deny coverage for TMS treatment. Plaintiff alleges that Aetna unlawfully failed to pay TMS claims by determining that TMS was an experimental, investigational, or unproven treatment, which violated the plans that Aetna administers and federal Employee Retirement Income Security Act (ERISA).
Class member who were in Aetna Plans administered by Aetna (or any of its operating divisions) and were denied health insurance coverage for TMS for the treatment of major depression using one of the codes for Experimental, Investigational, or Unproven Services between September 3, 2009 and July 29, 2016.
Amount of Class Members
At least $1,500.
Proof of Purchase
Depending on the nature of your specific claim, you may need to provide supporting materials.
NOTE: Do NOT file a claim if you do not qualify for this settlement.
Claim form Deadline
Meidl v. Aetna Inc., et al. No. 3:15-cv-1319-JCH, in the U.S. District Court for the District of Connecticut.
Settlement Website Status
D. Brian Hufford, Jason Cowart, and Andrew N. Goldfarb of Zuckerman Spaeder LLP;
Meiram Bendat of Psych Appeal, Inc.